STOCK TITAN

Blueberries Medi - BBRRF STOCK NEWS

Welcome to our dedicated page for Blueberries Medi news (Ticker: BBRRF), a resource for investors and traders seeking the latest updates and insights on Blueberries Medi stock.

Blueberries Medical Co (BBRRF) is a leading medical cannabis company focused on the production and distribution of pharmaceutical-grade cannabis products. With a strong presence in Latin America, the company is known for its innovative research, state-of-the-art facilities, and commitment to patient care. Blueberries Medical Co is dedicated to improving the quality of life for individuals through the therapeutic benefits of medical cannabis.

Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) reported a 110% increase in revenue for the year ended December 31, 2021, totaling $138,747. The company faced challenges due to market conditions and regulatory impacts but anticipates growth following the approval of Decree 811 allowing exports of dried cannabis from Colombia. Despite an increase in revenues, the company incurred a substantial net loss of $5,147,012 and recognized significant impairments on assets totaling $3,388,518. The management is focused on cash management and establishing processing capabilities to drive future sales growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.01%
Tags
-
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) reported significant financial growth for the nine months ended September 30, 2021. Revenue surged by 339% to $173,886, up from $39,607 in the same period last year. Gross margin increased to 63%, while the company successfully reduced operating expenses by 55%, amounting to around $1,932,072. Notable achievements include the export of 150kg of CBD oil to Peru, marking its largest sale to date, and securing regulatory approval for new agricultural operations in Colombia. The company's cash position improved substantially following a private placement of $1.9 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.64%
Tags
-
Rhea-AI Summary

Blueberries Medical Corp. (OTC: BBRRF) announced that its subsidiary in Colombia secured registration as a plant breeding unit and seed exporter. This authorization from the Colombian Agricultural Institute allows the company to enhance research on new cultivars, improving yield, cannabinoid profiles, and agronomic management. Additionally, the ability to export seeds opens up emerging market opportunities in Latin America. Executives highlighted the potential for income generation and international sales expansion, particularly in Argentina and Uruguay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
none
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) announced a significant milestone with its subsidiary Blueberries SAS exporting 150 kg of premium CBD oil to Futura Farms Peru. This transaction marks the largest sale since its inception in 2018, benefiting approximately 2,500 patients in Peru. The company aims to enhance its revenue generation, expecting over 700% growth compared to the previous fiscal year, supported by a recent USD 1.5M capital injection for operations and expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.14%
Tags
none
-
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM, OTC: BBRRF) announces its Annual General Meeting (AGM) scheduled for Wednesday, September 29, 2021, at 1:00 PM Eastern Time. Due to COVID-19 restrictions, the meeting will be held online, and in-person attendance will require proof of vaccination. Shareholders are encouraged to vote by proxy ahead of the meeting. The AGM will include a management update and presentation following formal proceedings. The deadline for proxy voting is September 27, 2021, at 1:00 PM Eastern Time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.41%
Tags
none
-
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM, OTC: BBRRF) has completed a non-brokered private placement, raising C$1,901,382 (approximately US$1.5 million) by issuing 20,813,817 common shares at C$0.10 each. The proceeds will be utilized for marketing strategies, equipment improvements, and certifications. Terraflos Inc. led the offering and recently closed an US$8 million funding round to expand its operations in Latin America. Additionally, Joaquín Barbera has been appointed as a new independent director, bringing expertise in innovation and sustainability to the board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
management
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM, OTC: BBRRF) reported financial results for Q2 2021, showing revenue growth to $14,785 from $4,644 in Q2 2020. The company reduced Selling General & Administrative Expenses significantly from $411,132 in H1 2020 to $209,114 in H1 2021. Despite these gains, Blueberries incurred a net loss of $269,067 in Q2 2021, a decrease from $814,084 in Q2 2020. The company is aligning strategies to minimize costs while expanding revenue through new services and partnerships in Colombia and Uruguay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.07%
Tags
-
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) reported financial results for Q1 2021, highlighting revenues of $23,120 compared to $0 in Q1 2020. The gross profit stood at $21,925, while net loss narrowed to $590,325 from $1,669,354 in the previous year. The company appointed Guillermo P. Rodriguez as CFO effective June 1, 2021. Blueberries continues to develop its cannabis operations, launching sales to Peru and preparing for domestic production in Colombia. Key achievements include a certification from LABFARVE for cannabis formulations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) has reported its 2020 financial results, indicating revenues of $65,978 from commercial cannabis operations after commencing sales in late Q2 2020. Despite significant cost-saving measures, the net loss narrowed to $4,940,107 from $10,787,876 in 2019. The company has focused on cash management, processing capabilities, and establishing sales growth amidst COVID-19 disruptions. Total assets decreased to $7,270,212 while total liabilities rose to $3,380,433.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.19%
Tags
Rhea-AI Summary

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) has announced a strategic agreement with Futura Farms to supply 200 kg of premium cannabis oil to Peru, marking its first entry into this market. Peru's medical cannabis market is projected to be worth US$99 million, and this partnership aligns with Blueberries' growth strategy across Latin America, including Colombia and the USA. The agreement is intended to cater to licensed pharmaceutical establishments compliant with Peru's Good Storage Practices. Both companies aim to enhance the quality of medical cannabis treatments in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
none

FAQ

What is the current stock price of Blueberries Medi (BBRRF)?

The current stock price of Blueberries Medi (BBRRF) is $0.0083 as of April 2, 2025.

What is the market cap of Blueberries Medi (BBRRF)?

The market cap of Blueberries Medi (BBRRF) is approximately 3.3M.

What does Blueberries Medical Co specialize in?

Blueberries Medical Co specializes in the production and distribution of pharmaceutical-grade medical cannabis products.

Where does Blueberries Medical Co operate?

Blueberries Medical Co has a strong presence in Latin America, with a focus on research, innovation, and patient care.

What sets Blueberries Medical Co apart from other cannabis companies?

Blueberries Medical Co stands out for its commitment to pharmaceutical-grade products, advanced facilities, and dedication to improving patient quality of life.

Does Blueberries Medical Co engage in research and development?

Yes, Blueberries Medical Co is actively involved in innovative research to enhance the therapeutic benefits of medical cannabis.

How does Blueberries Medical Co contribute to the medical cannabis industry?

Blueberries Medical Co contributes to the industry by setting high standards for quality, safety, and patient care in the production of medical cannabis products.

What is the mission of Blueberries Medical Co?

The mission of Blueberries Medical Co is to improve the quality of life for individuals through the therapeutic benefits of medical cannabis.

Does Blueberries Medical Co have any notable partnerships?

Blueberries Medical Co collaborates with industry leaders to drive innovation, expand market reach, and enhance patient care.

What are some of the core values of Blueberries Medical Co?

Some core values of Blueberries Medical Co include integrity, quality, innovation, and compassion for patients.

How does Blueberries Medical Co ensure product quality and safety?

Blueberries Medical Co maintains strict standards for product quality and safety through rigorous testing, compliance with regulations, and continuous improvement initiatives.

What are the future plans and goals of Blueberries Medical Co?

Blueberries Medical Co aims to expand its market presence, introduce new product lines, and continue advancing research efforts to offer cutting-edge medical cannabis solutions.
Blueberries Medi

OTC:BBRRF

BBRRF Rankings

BBRRF Stock Data

3.33M
56.02M
61.89%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver